Injectable Drug Delivery Market Size to Reach USD 83.38 Billion in 2030

Special Instructions [verticals to Target] – Healthcare, Pharmaceutical, Medical, Injectables, Pre-Filled Syringes, Auto-Injectors, Pen-Injectors, Hospitals, Homecare Settings, Clinics

 

VANCOUVER, B.C., Mar. 30, 2022 /PRNewswire/ --The global injectable drug delivery market size reached USD 15.13 Billion in 2021 and is expected to register a significantly rapid revenue CAGR during the forecast period, according to latest analysis by Emergen Research. Increasing application in medical surgeries is a major factor driving market revenue growth.

Drivers:

Injectable contraceptives are another development driving demand for injectable drug delivery. A hormone injection intended to prevent a woman from becoming pregnant is known as a contraceptive injection. The main component is Depot Medroxyprogesterone Acetate (DMPA). It is an injectable contraceptive that gives three months of highly efficient reversible contraception. By releasing DMPA, a progestin, the shot slows ovulation and thickens cervical mucus. It also helps to keep sperm from fertilizing eggs. A clinician can inject DMPA into the patient's muscle, or the patient can inject it oneself at home. The shot, however, must be evaluated every 12 weeks for it to be effective.

Get Free Sample PDF Copy of the Report@ https://www.emergenresearch.com/request-sample/112

The non-contraceptive benefits of the DMPA shot are numerous. DMPA, for example, does not have the same major estrogen-related adverse effects as estrogen, such as thrombosis. Dysmenorrhea is also less common, as are the chances of endometrial and ovarian cancer. Furthermore, because it is estrogen-free, it is suitable for women who are unable to take estrogen-containing products. It is also suitable for women who are breastfeeding.

Restraints:

Even though the fact that chronic diseases such as hormonal and autoimmune disorders are becoming more common globally, several issues are inhibiting the market growth. The high cost of modern injectable products is an example of this. Furthermore, when modern technologies such as pen-injectors and auto-injectors are employed, the expense of treating conditions such as Type I diabetes is higher. Furthermore, the lack of suitable reimbursement rules has impeded the adoption of these items and devices, particularly in developing countries. People in emerging economies prefer traditional injectable medicines over sophisticated ones due to the aforementioned considerations, posing a huge market challenge.

Growth Projections:

The global injectable drug delivery market is expected to register a CAGR of 9.1% over the forecast period and revenue is projected to increase from USD 15.13 Billion in 2021 to USD 83.38 Billion in 2030. Increasing investments by prominent market players is one of the major factors propelling market revenue growth.

COVID-19 Impact Analysis:

The COVID-19 pandemic had both positive and negative effects on the healthcare industry. Hospital systems were overburdened, putting enormous strain on the availability of medical supplies for each patient and the hospital. Furthermore, the growing demand for medical supplies such as injections, pre-filled syringes, and others led manufacturers' to increase production capacity to meet the demand-supply balance. Even though the fact that the COVID-19 pandemic had a negative impact on the supply chain of certain injectable drug delivery systems due to frequent lockdowns and limited cross-border trade, the market is gaining traction now that trade restrictions have been lifted.

Discount Available on Injectable Drug Delivery market report [Click Here]@ https://www.emergenresearch.com/request-discount/112

Current Trends and Innovations:

Following the COVID-19 pandemic, a greater emphasis has been placed on cleanliness and safety, and many pharmaceutical companies have begun to improve their packaging and sterilization supplies. They also began to change and upgrade their supplier offerings. For instance, in December 2021, Comar, LLC, a leading provider of custom medical devices and specialty packaging solutions, based in Voorhees Township, New Jersey, US announced the acquisition of Omega Packaging, a manufacturer of injection and blow-molded products for the pharmaceutical, nutraceutical, and skincare markets to provide effective child-resistant closures and jar products to serve healthcare customers. As a result, future merger & acquisition strategies are more likely to include high-end products, increasing market demand.

Geographical Outlook:

Market in Asia Pacific accounted for second-largest revenue share in 2021, because of increasing demand for injectable drug delivery devices from healthcare industry. China is expected to play a significant role in the region's market expansion. China's government is boosting its spending on healthcare, creating a climate that is conducive to the development of novel pharmaceuticals in the country. Moreover, due to abundant low-cost raw materials and increasing demand for branded pharmaceuticals, a number of foreign pharmaceutical companies are looking to expand their operations in China.

Strategic Initiatives:

Major companies included in the global market report include Vetter Pharma, Akorn Operating Company LLC, Catalent, Inc., Pfizer Inc., Gerresheimer AG, Elcam Medical, Schott, SHL Medical AG, Becton, Dickinson & Company, and West Pharmaceutical Services, Inc.

  • In January 2020, DALI Medical Systems, a Yavne, Israel-based manufacturer and distributor of drug delivery devices, introduced the SAN-Light passive safety needle with a revolutionary medication product that allows for easy administration. SAN-Light is a single-use hypodermic safety needle that works with any Luer-lock syringe for drug delivery.

Explore Complete Report Description and Table of Contents of Injectable Drug Delivery Market Report@ https://www.emergenresearch.com/industry-report/injectable-drug-delivery-market

Emergen Research has segmented global injectable drug delivery market on the basis of device type, product type, end-use, and region:

Get Customized Report as Per Your Specific Requirement@ https://www.emergenresearch.com/request-for-customization/112

  • Regional Outlook (Revenue, USD Million; 2019-2030)
    • North America
      1. US
      2. Canada
      3. Mexico
    • Europe
      1. Germany
      2. France
      3. UK
      4. Italy
      5. Spain
      6. Benelux
      7. Rest of Europe
    • Asia Pacific
      1. China
      2. India
      3. Japan
      4. South Korea
      5. Rest of APAC
    • Latin America
      1. Brazil
      2. Rest of LATAM
    • Middle East & Africa
      1. Saudi Arabia
      2. UAE
      3. South Africa
      4. Turkey
      5. Rest of MEA

Latest Reports Published by Emergen Research:

Next Generation Ultrasound System Market, By Portability (Portable Systems, Trolley Based Systems, and Others), By Product Type (Therapeutic Ultrasound, Diagnostic Ultrasound), By Application, By Technology, By End-Use, and By Region Forecast to 2028.

Cell Expansion Market By Product (Consumables, Instruments, Bioreactors), By Cell Type (Mammalian, Microbial), By Application, By End-user, and By Region Forecast to 2027.

Medical Grade Tubing Market Size, Share, Trends, By Material (Polyvinyl Chloride, Polyolefin, Thermoplastic elastomer and thermoplastic polyurethane, Silicone), By Application (Bulk Disposable Tubing), By Structure and By Region Forecast to 2030.

3D Organ Printing Market, By Material (Living Cells, Hydrogels, Extracellular Matrices, Other Biomaterials), By Printing Component (Inkjet Printing, Extrusion Printing, Laser-Assisted Printing), By End-use, and By Region Forecast to 2030.

Immunocytokines Market Size, Share, Trends, By Disease Indication (Tumor and Cancer, Rheumatoid Arthritis), By Targeting Site (Liver, Hypothalamus, Fat Muscle, B and T Lymphocytes, Bone Marrow Endothelium), and By Region Forecast to 2028.

Pilates and Yoga Studios Market Size, Share, Trends, By Type (Yoga Classes, Pilates Classes, Pilates & Yoga Accreditation Training), By Application, By Enterprise Size, By Sales Channel, and By Region Forecast to 2030

About Emergen Research

Emergen Research is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behavior shifts across demographics, across industries, and help clients make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Types, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trend’s existent in the market. Emergen Research has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.

Contact Us:

Eric Lee

Corporate Sales Specialist

Emergen Research | Web: www.emergenresearch.com

Direct Line: +1 (604) 757-9756

E-mail: sales@emergenresearch.com

Visit for More Insights: https://www.emergenresearch.com/insights

Explore Our Custom Intelligence services | Growth Consulting Services

Read our Press Release on Injectable Drug Delivery @ https://www.emergenresearch.com/press-release/global-injectable-drug-delivery-market

 

Back to news